Tele-Sox: A Tele-Medicine solution based on wearables and gamification to prevent Venous thromboembolism in Oncology Geriatric Patients

PROJECT SUMMARY/ABSTRACT Venous thromboembolism (VTE) is a leading cause of preventable hospital death in the US resulting in greater than 100,000 deaths annually. Advanced age, surgery, cancer, immobilization, and hospitalization are common causes of VTE. Overall, 20% of all VTE cases occurs in patients who have cancer. VTE was also a significant predictor of mortality during the first year of diagnosis in patients with all types of cancer. Not only the risk of VTE is high in the hospitalized patients because of long immobility, its risk remains elevated up to 3 months after discharge. VTE is also highly prevalent among COVID-19 patients even after the hospital discharge. Current methods of prophylaxis for VTE have significant limitations. For instance, the use of pharmacologic prophylaxis is mostly limited to the inpatient setting, due to increased rates of bleeding complications. Current non-pharmacological interventions are inefficient due to lack of compliance, impracticality for in-home care, cost, and supervision requirements especially in elderly population. To address the limitations described above STEXOLE LLC is partnered with Baylor College of Medicine (BCM) to design and commercialize an innovative tele-medicine-based smart sock named Tele-SOX. This device includes three major components: 1) Sensor-Exergame: a patented interactive game- based foot and ankle exercise program based on a wearable sensor, which will be integrated into the sock and enables delivering personalized game-based lower extremity exercise, ensuring improving venous return and prevention of VTE; 2) a series of adjustable weights add-on to socks to personalized resistive exercise; 3) tele- medicine: a mobile application installable on a tablet or a smart phone enables interaction with care providers as well as guiding patients to execute effective and personalized exercise tasks and gamification features to engage patient and remind him/her for recommended dosage of needed exergame per day. The scientific premise of the proposed platform relies on our initial study demonstrating effectiveness of the proposed exergame program on increasing venous blood flow volume on average by 49% after just 3-minute interactive and virtually supervised repetitive foot and ankle exercise, while reducing hospital acquired weakness. During Phase I, the initial platform will be improved to make it suitable for home-based use and non-tech savvy users (Aim 1). In addition, the proof of concept of the platform will be assessed in a convenient sample of 15 geriatric oncology inpatients (age 50+) to demonstrate its feasibility and proof of concept efficacy to improve venous-return flow in response to 3-5 min usage of the device (Aim 2). Finally, by interviewing recruited participants and 15 clinical experts unaffiliated with the project, we will assess perception of benefit and ease of use. After successful achievement of the milestones of the Phase I, During Phase II, the gaming interface will be further developed (more games, inter-connectivity of patients), and will be tested for its effectiveness to reduce risk of VTE, improve mobility, reduce readmission risk, and enhancing the quality of life.